11
Jul
Jul
In a recent study published in The Lancet Infectious Diseases, researchers determine the security and immunogenicity of a novel candidate vaccine against Lyme borreliosis. Study: Safety and immunogenicity of a novel multivalent OspA-based vaccine candidate against Lyme borreliosis: a randomised, phase 1 study in healthy adults. Image Credit: Evgeniyqw / Shutterstock.com What’s Lyme disease? Lyme borreliosis is a tick-borne […]